Gothenburg, October 9, 2026 — IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that CEO Kristina Torfgård will present IRLAB at Redeye Theme: Neurology on October 15 in Stockholm.
Both Swedish and international investors will participate in the meeting, providing the company with excellent opportunities to expand its network and establish new contacts.
The event will be held at Redeye's office at Mäster Samuelsgatan 42 in Stockholm.
The presentation will also be broadcasted live via the link below and will be available afterwards on Redeye's website and social media.
More information about the meeting: https://www.redeye.se/events/1145293/redeye-theme-neurology-4